Prc was Baird Medical Investment Holdings’s largest region in fiscal 2025, bringing in $40.49M of $67.61M (60%).
| Geography | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Prc | $94.37M | $108.55M | $40.49M |
| Hong Kong | — | — | $23.97M |
| United States | — | $2.56M | $2.82M |
| Malaysia | — | — | $318.01K |
| Nepal | — | — | $25.44K |
| Total | $94.37M | $111.11M | $67.61M |
Baird Medical Investment Holdings brought in $67.61M from its five regions in fiscal 2025, the year ended December 31, 2025. Baird Medical Investment Holdings regrouped these regions after fiscal 2024, so the total does not compare directly with that year's $111.11M. Prc was the largest at $40.49M (59.9%), ahead of Hong Kong at $23.97M (35.4%) and United States at $2.82M (4.2%). The other two regions brought in $343.44K combined.
Compared with fiscal 2024, United States grew 10.2% to $2.82M, while Prc fell 62.7% to $40.49M.
Baird Medical Investment Holdings began breaking out Hong Kong in fiscal 2025, United States in fiscal 2024, Malaysia in fiscal 2025 and Nepal in fiscal 2025.
Mwa Needles was Baird Medical Investment Holdings’s largest product and service line in fiscal 2025, bringing in $51.64M of $67.61M (76%).
| Product and Service | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Mwa Needles | $91.65M | $78.83M | $101.48M | $51.64M |
| Mwa Therapeutic Apparatus | $2.20M | $13.99M | $9.60M | $15.97M |
| Other Medical Devices | $11.42M | $1.55M | $29.49K | — |
| Total | $105.27M | $94.37M | $111.11M | $67.61M |
Baird Medical Investment Holdings brought in $67.61M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. Baird Medical Investment Holdings regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $111.11M. Mwa Needles was the largest at $51.64M (76.4%), ahead of Mwa Therapeutic Apparatus at $15.97M (23.6%).
Compared with fiscal 2024, Mwa Therapeutic Apparatus grew 66.3% to $15.97M, while Mwa Needles fell 49.1% to $51.64M.
Baird Medical Investment Holdings stopped reporting Other Medical Devices as a separate line after fiscal 2024, when it brought in $29.49K.
Distributors was Baird Medical Investment Holdings’s largest revenue line in fiscal 2025, bringing in $55.22M of $67.61M (82%).
| Customer | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Distributors | $40.50M | $44.99M | $51.66M | $55.22M |
| Direct Customers | $64.78M | $49.39M | $59.45M | $12.39M |
| Total | $105.27M | $94.37M | $111.11M | $67.61M |
Baird Medical Investment Holdings brought in $67.61M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was down 39.2% from $111.11M in fiscal 2024. Distributors was the largest at $55.22M (81.7%), ahead of Direct Customers at $12.39M (18.3%).
Compared with fiscal 2024, Distributors grew 6.9% to $55.22M, while Direct Customers fell 79.2% to $12.39M. From fiscal 2022 to 2025, combined revenue from these revenue lines fell from $105.27M to $67.61M, a compound annual decline of 13.7%. Distributors' share of the total rose from 38.5% to 81.7%.
Baird Medical Investment Holdings (BDMD) reports its revenue by geography, by product and service and by customer. In fiscal 2025, Prc was its largest region, bringing in $40.49M (59.9% of the total), followed by Hong Kong at $23.97M (35.4%).
Prc was Baird Medical Investment Holdings' largest region in fiscal 2025, bringing in $40.49M, or 59.9% of the $67.61M total across its five regions.
Mwa Needles was Baird Medical Investment Holdings' largest product and service line in fiscal 2025, bringing in $51.64M, or 76.4% of the $67.61M total across its two product and service lines.
Distributors was Baird Medical Investment Holdings' largest revenue line in fiscal 2025, bringing in $55.22M, or 81.7% of the $67.61M total across its two revenue lines.
Distributors grew faster than Direct Customers in fiscal 2025, up 6.9% from $51.66M to $55.22M. Direct Customers fell 79.2% to $12.39M.
Every figure comes from Baird Medical Investment Holdings' annual financial filings, as reported. Each line keeps the name Baird Medical Investment Holdings gives it, and years follow its fiscal calendar.
Baird Medical Investment Holdings' revenue by geography goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.